RecallRadar

FDA Drug recall D-1233-2020

Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East…

On 2020-04-22 the FDA classified a Class II recall of Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East… by Aurobindo Pharma Usa, citing CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1233-2020
ClassificationClass II
Statusterminated
Initiated2020-03-18
Published2020-04-22
Last updated2026-09-13 11:52 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08

Reason

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Identifiers

ndc65862-245-08
ndc65862-245-05
ndc65862-246-08
ndc65862-246-05
ndc65862-247-08
ndc65862-247-05
ndc65862-315-30
ndc65862-315-60
ndc65862-315-05
code_infoLot #: 24719001A1, Exp. Date 03/2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1233-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.